These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 22430147)

  • 41. Skeletal Muscle Myopathy in Heart Failure: the Role of Ejection Fraction.
    Paneroni M; Pasini E; Comini L; Vitacca M; Schena F; Scalvini S; Venturelli M
    Curr Cardiol Rep; 2018 Sep; 20(11):116. PubMed ID: 30259199
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clenbuterol increases lean muscle mass but not endurance in patients with chronic heart failure.
    Kamalakkannan G; Petrilli CM; George I; LaManca J; McLaughlin BT; Shane E; Mancini DM; Maybaum S
    J Heart Lung Transplant; 2008 Apr; 27(4):457-61. PubMed ID: 18374884
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inefficient ventilation and reduced respiratory muscle capacity in congestive heart failure.
    Meyer FJ; Zugck C; Haass M; Otterspoor L; Strasser RH; Kübler W; Borst MM
    Basic Res Cardiol; 2000 Aug; 95(4):333-42. PubMed ID: 11005589
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hypoxia preconditioning by cobalt chloride enhances endurance performance and protects skeletal muscles from exercise-induced oxidative damage in rats.
    Saxena S; Shukla D; Saxena S; Khan YA; Singh M; Bansal A; Sairam M; Jain SK
    Acta Physiol (Oxf); 2010 Nov; 200(3):249-63. PubMed ID: 20384596
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Markedly improved skeletal muscle function with local muscle training in patients with chronic heart failure.
    Gordon A; Tyni-Lenné R; Persson H; Kaijser L; Hultman E; Sylvén C
    Clin Cardiol; 1996 Jul; 19(7):568-74. PubMed ID: 8818438
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inspiratory muscle training in patients with heart failure and inspiratory muscle weakness: a randomized trial.
    Dall'Ago P; Chiappa GR; Guths H; Stein R; Ribeiro JP
    J Am Coll Cardiol; 2006 Feb; 47(4):757-63. PubMed ID: 16487841
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Clinical consequences of muscle dysfunction in chronic obstructive pulmonary disease].
    Sauleda Roig J
    Nutr Hosp; 2006 May; 21 Suppl 3():69-75. PubMed ID: 16768033
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Value of training-induced effects on arterial vascular system and skeletal muscles in therapy of NYHA II/III heart failure].
    Huonker M; Keul J
    Z Kardiol; 2001 Nov; 90(11):813-23. PubMed ID: 11771449
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Systemic inflammation and skeletal muscle dysfunction in chronic obstructive pulmonary disease: state of the art and novel insights in regulation of muscle plasticity.
    Remels AH; Gosker HR; van der Velden J; Langen RC; Schols AM
    Clin Chest Med; 2007 Sep; 28(3):537-52, vi. PubMed ID: 17720042
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cores in hypothyroid myopathy: a clinical, histological and immunofluorescence study.
    Modi G
    J Neurol Sci; 2000 Apr; 175(1):28-32. PubMed ID: 10785253
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Muscle wasting in cardiac cachexia.
    Strassburg S; Springer J; Anker SD
    Int J Biochem Cell Biol; 2005 Oct; 37(10):1938-47. PubMed ID: 15927519
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Severe acute myopathy following SARS-CoV-2 infection: a case report and review of recent literature.
    Islam B; Ahmed M; Islam Z; Begum SM
    Skelet Muscle; 2021 Apr; 11(1):10. PubMed ID: 33883014
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evidence of reduced respiratory muscle endurance in patients with heart failure.
    Mancini DM; Henson D; LaManca J; Levine S
    J Am Coll Cardiol; 1994 Oct; 24(4):972-81. PubMed ID: 7930233
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neuromuscular disease and respiratory failure.
    Hutchinson D; Whyte K
    Pract Neurol; 2008 Aug; 8(4):229-37. PubMed ID: 18644909
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Peripheral abnormalities in chronic heart failure.
    Adamopoulos S; Coats AJ
    Postgrad Med J; 1991; 67 Suppl 1():S74-9; discussion S79-80. PubMed ID: 1924083
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cardiac cachexia: a syndrome with impaired survival and immune and neuroendocrine activation.
    Anker SD; Coats AJ
    Chest; 1999 Mar; 115(3):836-47. PubMed ID: 10084500
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Peripheral muscles in COPD: deconditioning or myopathy?].
    Montes de Oca M; Celli BR
    Arch Bronconeumol; 2001 Feb; 37(2):82-7. PubMed ID: 11181243
    [No Abstract]   [Full Text] [Related]  

  • 58. Relation of systemic and local muscle exercise capacity to skeletal muscle characteristics in men with congestive heart failure.
    Massie BM; Simonini A; Sahgal P; Wells L; Dudley GA
    J Am Coll Cardiol; 1996 Jan; 27(1):140-5. PubMed ID: 8522687
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Metabolic, morpho-histologic and biochemical changes in skeletal muscles in chronic cardiac failure].
    Chati Z; Zannad F
    Arch Mal Coeur Vaiss; 1994 Jun; 87 Spec No 2():17-26. PubMed ID: 7864718
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of physical training on skeletal muscle in patients with chronic heart failure.
    Kiilavuori K; Näveri H; Salmi T; Härkönen M
    Eur J Heart Fail; 2000 Mar; 2(1):53-63. PubMed ID: 10742704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.